Bicocca Open Archive

Logo unimib boa
PIROLA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.928
EU - Europa 2.645
AS - Asia 1.107
SA - Sud America 55
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 8.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.836
DE - Germania 598
SG - Singapore 462
IT - Italia 461
SE - Svezia 379
CN - Cina 370
IE - Irlanda 322
RU - Federazione Russa 318
UA - Ucraina 187
GB - Regno Unito 141
HK - Hong Kong 93
CA - Canada 90
FR - Francia 59
FI - Finlandia 58
BR - Brasile 45
TR - Turchia 37
VN - Vietnam 36
IN - India 35
DK - Danimarca 34
BE - Belgio 31
ID - Indonesia 28
NL - Olanda 17
JP - Giappone 12
AT - Austria 9
IR - Iran 9
EU - Europa 7
CH - Svizzera 6
KR - Corea 6
PL - Polonia 6
CZ - Repubblica Ceca 5
AR - Argentina 4
AU - Australia 3
LT - Lituania 3
PE - Perù 3
RO - Romania 3
ZA - Sudafrica 3
AM - Armenia 2
GR - Grecia 2
KE - Kenya 2
LV - Lettonia 2
MX - Messico 2
MY - Malesia 2
PK - Pakistan 2
SA - Arabia Saudita 2
SC - Seychelles 2
TH - Thailandia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.757
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.069
Woodbridge 418
Fairfield 378
Chandler 347
Houston 343
Frankfurt am Main 322
Dublin 312
Singapore 293
Ashburn 279
Wilmington 247
Dearborn 225
Milan 219
Jacksonville 177
Seattle 168
Cambridge 123
New York 114
Hong Kong 93
Santa Clara 89
Princeton 86
Nanjing 64
Göttingen 61
Shanghai 54
Beijing 45
Altamura 37
Lawrence 36
Brussels 31
Lachine 29
Boardman 28
Jakarta 28
Ottawa 28
Shenyang 25
Nanchang 24
Dong Ket 23
Moscow 23
Fürstenwalde 21
San Diego 21
Guangzhou 20
Helsinki 20
Los Angeles 20
Munich 20
Andover 19
Fremont 19
Kocaeli 19
Falls Church 17
Hebei 16
Council Bluffs 15
Tianjin 15
Toronto 15
Lissone 13
London 13
Jiaxing 12
Kunming 12
Nuremberg 12
Edmonton 11
Jinan 11
Norwalk 11
Lauterbourg 10
Pavia 10
Pune 10
Düsseldorf 9
Romola 9
Changsha 8
Kiev 8
Nürnberg 8
Redmond 7
Bonndorf 6
Espoo 6
Hefei 6
Lodz 6
Zanjan 6
Chicago 5
Dallas 5
Huizen 5
Ningbo 5
Portsmouth 5
Taku 5
Marseille 4
Mountain View 4
Mumbai 4
Paullo 4
Phoenix 4
Vienna 4
Washington 4
Auburn Hills 3
Bari 3
Birmingham 3
Boston 3
Daejeon 3
Kilburn 3
Leawood 3
Meaux 3
Montréal 3
Motta Di Livenza 3
Olomouc 3
Quartu Sant'elena 3
Rome 3
São Paulo 3
Zhengzhou 3
Acton 2
Bangalore 2
Totale 6.406
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 422
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 375
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 322
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 314
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 301
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 300
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 288
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 285
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 285
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 279
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 240
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 239
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 229
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 226
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 221
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 219
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 219
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 211
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 210
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 209
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 192
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 189
Whole-Exome Sequencing Data - Identifying Somatic Mutations 188
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 186
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 179
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 176
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 174
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 171
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 170
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 170
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 168
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 164
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 162
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 158
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 157
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 155
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 145
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 135
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 132
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 124
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 105
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 103
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 95
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 90
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 68
Totale 9.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 0 0 0 0 0 127 94 36
2020/20211.392 70 71 149 166 118 116 145 130 106 134 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.416 135 166 120 97 194 74 113 72 164 281 0 0
Totale 9.150